FDA Citizen Petition #6: Benzene in Body Spray Products
On November 4, 2021, Valisure announced the detection of high levels of benzene, a known human carcinogen, in several brands and batches of antiperspirant body sprays, which are considered drug products by the Food and Drug Administration (FDA), as well as in deodorant body spray products, which FDA generally regulates as cosmetics.
Valisure analyzed 108 unique batches from 30 different brands. Even within a single brand, significant variability from batch to batch variability was observed. 24 lots of body spray products from 8 brands contained between 2.24 – 17.7 ppm of benzene; 14 lots of 8 brands included detectable benzene between 0.20 – 1.89 ppm; and 21 lots contained detectable benzene. Benzene was not detected in an additional 49 lots of body sprays from 19 different brands.
Media Highlights:
Related Documents:
- Press Release - Valisure Detects Benzene in Body Spray Products
- Attachment A – Resolution from the American College of Cardiology regarding independent testing
- Please read about Responsible Disposal of Potentially Contaminated Products
- FDA Citizen Petition – Contains lists of products where benzene was detected and not detected
- Summary Timeline of consumer product recalls due to benzene
View Other Newsroom Posts
View Other Newsroom Posts
On November 4, 2021, Valisure announced the detection of high levels of benzene, a known human carcinogen, in several brands and batches of antiperspirant body sprays, which are considered drug products by the Food and Drug Administration (FDA), as well as in deodorant body spray products, which FDA generally regulates as cosmetics.
Valisure analyzed 108 unique batches from 30 different brands. Even within a single brand, significant variability from batch to batch variability was observed. 24 lots of body spray products from 8 brands contained between 2.24 – 17.7 ppm of benzene; 14 lots of 8 brands included detectable benzene between 0.20 – 1.89 ppm; and 21 lots contained detectable benzene. Benzene was not detected in an additional 49 lots of body sprays from 19 different brands.
Media Highlights:
Related Documents:
- Press Release - Valisure Detects Benzene in Body Spray Products
- Attachment A – Resolution from the American College of Cardiology regarding independent testing
- Please read about Responsible Disposal of Potentially Contaminated Products
- FDA Citizen Petition – Contains lists of products where benzene was detected and not detected
- Summary Timeline of consumer product recalls due to benzene
On November 4, 2021, Valisure announced the detection of high levels of benzene, a known human carcinogen, in several brands and batches of antiperspirant body sprays, which are considered drug products by the Food and Drug Administration (FDA), as well as in deodorant body spray products, which FDA generally regulates as cosmetics.
Valisure analyzed 108 unique batches from 30 different brands. Even within a single brand, significant variability from batch to batch variability was observed. 24 lots of body spray products from 8 brands contained between 2.24 – 17.7 ppm of benzene; 14 lots of 8 brands included detectable benzene between 0.20 – 1.89 ppm; and 21 lots contained detectable benzene. Benzene was not detected in an additional 49 lots of body sprays from 19 different brands.
Media Highlights:
Related Documents:
- Press Release - Valisure Detects Benzene in Body Spray Products
- Attachment A – Resolution from the American College of Cardiology regarding independent testing
- Please read about Responsible Disposal of Potentially Contaminated Products
- FDA Citizen Petition – Contains lists of products where benzene was detected and not detected
- Summary Timeline of consumer product recalls due to benzene
![]()
View Other Newsroom Posts